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Abstract
Pancreatic fluid collections (PFCs) are a frequent complication of acute 
pancreatitis. PFCs have been categorized according to their content and duration 
after an episode of pancreatitis. Acute collections (<4 week) and asymptomatic 
late collections (>4 weeks) can be usually managed conservatively. Late collec-
tions including walled off necrosis (WON) and pancreatic pseudocysts (PP) have 
a well-defined wall. Consequently, it is easier and safer to drain these collections 
when required. The most common indication to drain PFCs is infection and the 
available means of drainage include surgical, endoscopic, and percutaneous. Open 
surgical interventions carry a high risk of morbidity and mortality. Therefore, 
in the current era, a step up approach is preferred to minimize morbidity over 
the more aggressive surgical treatments. Endoscopic step-up approach is effec-
tive and favored over minimally invasive surgical or percutaneous drainage due 
to reduced risk of organ failure and external pancreatic fistula. However, the 
approach to PFCs should be individualized for optimal outcomes. A small sub-
group of patients does not respond to endotherapy or percutaneous interventions 
and requires open surgical debridement. Similarly, not all PFCs are amenable 
to endoscopic drainage and demand alternative modalities like percutaneous or 
minimally invasive surgical drainage.
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1. Introduction
Acute pancreatitis is mild in majority of the cases and categorized as interstitial 
edematous pancreatitis. About 15–20% of cases develop necrotizing pancreatitis 
involving necrosis of variable proportion of pancreatic parenchyma. Pancreatic 
fluid collections (PFCs) are a common local complication of acute pancreatitis. 
PFCs have been classified according to the revised Atlanta criteria based on dura-
tion (<4 or >4 weeks) and contents of fluid collection [1]. Acute collections include 
acute pancreatic or peri-pancreatic fluid collections (APFCs) and acute necrotic 
pancreatic fluid collections (ANPFCs) which develop after acute interstitial and 
acute necrotizing pancreatitis, respectively (Figure 1). APFCs and ANPFCs get 
walled off after about 4–6 weeks into pseudocysts and walled off necrosis (WON), 
respectively. By definition, pseudocysts have clear contents and WON consists of 
variable amount of necrotic debris (Figures 2 and 3).
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Figure 3. 
Endosonographic image in a case with walled off necrosis. Not the well-defined boundaries with echogenic 
necrotic debris in the cyst cavity.
Figure 1. 
Endosonographic image of acute necrotic pancreatic fluid collections. Note the ill-defined boundaries and the 
solid component within the fluid collection.
Figure 2. 
Endosonographic image in a case with pancreatic pseudocyst. Not the well-defined boundaries without any 
echogenic debris in the cyst cavity.
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1.1 Natural history of pancreatic fluid collections
APFCs develop in about 20–40% of patients after acute interstitial pancreatitis 
[2–4]. Majority (~90%) of APFCs resolve and do not transform into pseudocyst. 
Moreover, majority of the pseudocysts resolve or reduce in size with time and there-
fore, do not require an intervention [4]. On the other hand, majority (90–100%) 
of the patients with acute necrotizing pancreatitis develop ANPFCs. Nearly half of 
the patients with ANPFCs develop walled off necrosis (WON) [2, 3]. The natural 
history of WON is not well known and appears to be more unpredictable than 
pseudocysts. An intervention may be required in one quarter to more than half of 
the patients with WON [2, 3].
2. Management of pancreatic fluid collections
The options of drainage for PFCs include surgery, percutaneous catheter drain-
age, and endoscopic transmural drainage (ETD). Open necrosectomy is associated 
with substantial rates of new onset multiple organ failure as compared to minimally 
invasive surgical step up approach (see later) [5]. Subsequent studies comparing 
endoscopic necrosectomy to open as well as minimally invasive surgical debride-
ment concluded the superiority of endoscopic approach [6, 7]. Reduced mortality, 
less frequent new onset multiple organ failure, and the development of pancreatic 
fistulas are distinct advantages of endoscopic necrosectomy [8, 9]. In the current 
era, a step up approach is preferred for its obvious benefits in reducing a pro-
inflammatory response and prevention of new onset organ failure. In the ensuing 
sections, we would discuss endoscopic approach to PFCs and its advantages over 
surgical and percutaneous drainages.
2.1 Endoscopic drainage of PFCs
Characterization of PFCs into pseudocysts and WON is important prior to 
ETD. WON has variable amount of necrotic debris and therefore, has a protracted 
course and more frequent requirement of re-interventions as compared to pseudo-
cysts (Figures 2 and 3). Computed tomography is frequently used to localize the site 
of collection. However, it may not accurately differentiate between the solid and liq-
uid contents of the collection (Figures 4 and 5). Magnetic resonance imaging (MRI) 
Figure 4. 
CT image in a case of pancreatic pseudocyst. Note the well-defined boundary and clear contents of the cyst.
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and endoscopic ultrasound (EUS) are better imaging modalities for qualitative assess-
ment of PFCs. We perform both CECT and EUS to define the anatomical relation of 
PFCs to the lumen and characterize them into pseudocyst or WON, respectively.
The technique of endoscopic drainage of PFCs involves the following steps: 
puncture of the cysto-gastric or cysto-duodenal wall using a 19 gauge needle 
and aspiration of cyst contents, coiling of guidewire within the cyst cavity under 
fluoroscopy guidance, dilatation of the tract using cystotome and balloon and 
deployment of plastic or metal endoprostheses. EUS guided drainage is preferred to 
endoscopic approach as intervening vessels can be avoided and non-bulging collec-
tions can be targeted under vision [10].
The success rate of ETD with or without endoscopic necrosectomy ranges from 
80 to 95% in recent studies [11–19] (Table 1). The outcomes of ETD of PFCs is 
variable in literature presumably due to heterogeneity in the nature of collection, 
that is, pseudocyst or WON, type of stent used, and whether necrosectomy is 
performed or not [20]. In addition, the presence of disconnected pancreatic duct 
(DPD) may impact the outcomes of ETD. The requirement of hybrid treatment, 
re-interventions, recurrences, and rescue surgery appear to be higher in the patients 
with DPD [21].
ETD of PFCs is safe, and major complications are uncommon. Complications 
related to ETD occur in 10–40% of patients with WON [22]. Supra-infection 
of the cyst cavity is the most common significant complication associated with 
ETD. Occlusion of the stent with necrotic debris and inadequate drainage may lead 
to sepsis. In such situations, de-clogging of the metal stent, cyst lavage with saline 
or diluted hydrogen peroxide and direct endoscopic necrosectomy (DEN) are often 
helpful. Other complications associated with ETD include bleeding and perforation. 
Recent studies have drawn attention towards the relatively high incidence of bleeding 
especially with the use of large caliber metal stents (LCMS) [23–25]. Since, majority of 
the bleeding episodes occurred ≥3 weeks after the deployment of LCMS, the current 
trend is to remove LCMS between 2 and 3 weeks in cases of resolution of PFC [24].
2.2 Endoscopic transmural drainage: choice of stents
Endoscopic drainage of PFCs can be performed using pigtail plastic stents or 
metal stents. Plastic stents have been effectively used for the drainage of PFCs for 
Figure 5. 
CT image in a case of walled off necrosis replacing almost entire pancreas. Note that the necrotic contents of the 
cyst cavity are not obvious in CT image.
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N PFC Type of stent Success Recurrence Adjuvant PCD or Sx Complications
Walter et al. [11] 61 PC 15
WON 46
LAMS
(AXIOS)
93%
81%
NR Sx 6.5% Infection 6.5%
Perforation 1.6%
Siddiqui et al. [12] 82 PC 12
WON 68
LAMS
(AXIOS)
100%
88.2%
1.2% PCD 5% Stent mal-deployment 
2.5%
Bleeding 7.5%
Sharaiha et al. [13] 124 All WON LAMS
(AXIOS)
86.3% 4.8% 10.5%/2.4% Infection 3.2%
Stent occlusion 4%
Stent migration 2.4%
Bleeding 1.4%
Lakhtakia et al. [14] 205 All WON Biflanged
(Nagi)
96.5% 2.4% 1%/1% Bleeding 2.9%
Perforation 1%
Venkatachalapathy 
et al. [15]
116 PC 46
WON 70
LAMS
(AXIOS)
94% 0.86% 2.5%/− Sepsis 6%
Stent occlusion 0.86%
Migration 0.8%
Bleeding 0.86%
Death 1.7%
Dhir et al. [16] 88 All WON Biflanged
(Nagi)
80.7% 9.1% Sx 1.1% Fever 13.6%
Stent migration 2.3%
Bleeding 3.4%
Yang et al. [17] 122 PC 58
WON 64
LAMS
(AXIOS)
96.5%
62.3%
NR Sx: 3.3% WON Bleeding 3.3%
Infection 4.8%
Kumta et al. [18] 192 PC 41
WON 151
LAMS (AXIOS) 92.6% 3.7% 7.3%/3.1% Bleeding 5.7%
Perforation 2.1%
Infection 2.1%
Teoh et al. [19] 59 PC 20
WON 39
LAMS
(SPAXUS)
100% 3.4% None Bleeding 5.1%
Perforation 1.7%
PFC, pancreatic fluid collection; PC, pseudocyst; WON, walled off necrosis; Sx, surgery; PCD, percutaneous drainage; NR, not reported; LAMS, lumen apposing metal stent.
Table 1. 
Outcome of endoscopic transmural drainage in pancreatic fluid collections using large caliber metal stents.
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several decades now. The proposed advantages of plastic over metal stents include 
lower cost, less risk of delayed bleeding, and ability to keep them for long term 
in cases with DPD. On the other hand, metal stents have wider lumen, allowing 
efficient drainage of the necrotic material and endoscopic necrosectomy when 
required. Conventional fully covered metal stents used initially were suboptimal 
due to their longer lengths and lack of lumen apposing properties. The development 
of novel LCMS has widened the therapeutic armamentarium for ETD of PFCs. 
Newly developed LCMS have either lumen apposing (AXIOS, Xlumena, Mountain 
View, CA, United States and Niti-S SPAXUS, TaeWoong Medical Co., Ltd., Ilsan, 
South Korea) properties or flared ends (NAGI, Taewoong Medical Co, Ilsan, South 
Korea) to prevent stent migration [10]. As compared to the conventional metal 
stents, the use of LCMS is associated with superior outcomes in terms of number 
of procedures required for the resolution of WON [26]. Similarly, better clinical 
outcomes and reduced requirement of endoscopic necrosectomy have been found 
with the use of metal stents as compared to plastic stents in several studies [27–30]. 
In a large, multicenter study including 189 patients with WON, the use of LCMS 
was associated with higher clinical success (80.4 vs. 57.5%), shorter procedure time, 
lower need for surgery (5.1 vs. 16.1%), and lower rate of recurrence as compared 
to plastic stents [31]. However, the superiority of LCMS is not uniform across the 
published studies. In a randomized trial, there was no significant difference in the 
treatment outcomes including the total number of procedures performed, treat-
ment success, and readmissions between LCMS and plastic stent groups in patients 
with WON [24]. In addition, the treatment cost (LCMS: US$12155 vs. plastic stents: 
US$6609) and stent related adverse events were higher in the LCMS group (32.3 vs. 
6.9%, p = 0.01) [24]. Several systematic reviews and meta-analyses draw conflict-
ing conclusions while comparing plastic stents vs. metal stents for ETD of PFCs 
[32–37]. In three of the published systematic reviews and meta-analyses, metal 
stents were found superior to plastic stents for both pseudocysts as well as WON in 
terms of clinical success and adverse events [34, 36, 32]. On the contrary, two other 
systematic reviews and meta-analyses did not find a difference in the outcomes 
between metal or plastic stents [33, 37]. It must be emphasized that the paucity of 
randomized trials is the major limitations of these reviews.
The current trend is to use metal stents for WON with significant debris. These 
cases may require more frequent re-interventions including endoscopic necro-
sectomy for which LCMS are ideal. Whereas, plastic stents are an cost effective 
alternative in pseudocysts or WON with minimal necrotic contents. Randomized 
trials are warranted before concluding the superiority of metal stents for the 
management of PFCs.
2.3 Endoscopic necrosectomy
Endoscopic necrosectomy essentially comprises of endoscopic debridement of 
necrotic debris within the cyst cavity using a variety of methods including DEN and 
naso-cystic lavage with saline and or diluted hydrogen peroxide (3%, 1:10 dilution). 
DEN involves the passage of endoscope within the cyst cavity followed by mechani-
cal removal of necrotic tissue using forceps, polypectomy snares, and retrieval nets 
[38]. With the availability of LCMS (≥15 mm), multiple sessions of DEN can be 
performed with relative ease. However, there is no dedicated device or accessory 
for DEN and therefore, the process is cumbersome and time consuming. Recent 
development of new devices to facilitate endoscopic debridement is likely to make 
DEN less cumbersome and more efficacious [39, 40].
DEN is safe and effective in about 80–90% of patients with WON. However, 
DEN may be associated with substantial complications. In a systematic review, the 
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overall rate of adverse events and mortality associated with endoscopic necrosec-
tomy were 22% and 5%, respectively. The complications reported with DEN include 
air embolism (0.4%), bleeding (11%), and perforation (3%) [41]. Therefore, DEN 
is usually performed in cases with no improvement after ETD alone.
Our group re-defined the endoscopic step-up approach in patients with 
WON. This approach includes cyst cavity lavage using nasocystic catheter and 
de-clogging of the metal stent as intermediate steps after transmural placement 
of metal stent and before proceeding to endoscopic necrosectomy [14]. With this 
approach, endoscopic necrosectomy can be avoided in the vast majority of patients 
with WON.
2.4 Step-up approach for walled of necrosis
Open surgery is associated with a high morbidity and mortality in patients with 
WON. Consequently, minimally invasive surgical or endoscopic approaches have 
virtually replaced open necrosectomy in these patients [6]. The available evidence 
favors a step-up approach over the conventional techniques [7, 42–44]. In general, 
minimally invasive surgical step-up approach consists of percutaneous drainage 
followed by (if necessary) video assisted retroperitoneal debridement (VARD). 
Whereas, endoscopic step up approach includes ETD followed by (if necessary) 
endoscopic necrosectomy. Percutaneous catheter drainage can be used as an adjunct 
to ETD in cases with incomplete response or large collections with extension into 
paracolic gutter (Figure 6).
Several trials have compared endoscopic versus minimally invasive surgical 
methods of drainage in cases with WON [7, 45]. In a randomized trial by the Dutch 
Pancreatitis Study Group, there was no difference in the incidence of major compli-
cations or mortality between the endoscopic or minimally invasive surgical step-up 
approach (endoscopy: 43% vs. surgery: 45%, p = 0.88) [7]. However, the rate of 
Figure 6. 
Large pancreatic fluid collection extending into pelvis.
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pancreatic fistulas (5 vs 32%, p < 0.01) and the length of hospital stay were lower 
in the endoscopy group [7]. In another randomized trial including 66 patients with 
infected WON, ETD was associated with significantly reduced major complications 
(0.15 vs. 0.69), lowered costs (75,830 $ vs. 117,492 $), lower incidence of pancreatic 
fistula (0 vs. 28.1%), and increased quality of life as compared to minimally invasive 
surgery [45]. In a recent systematic review including two randomized trials and four 
observational studies, ETD was associated with lower mortality, risk of major organ 
failure, adverse events, and length of hospital stay [44]. These trials suggest that 
endoscopic step-up approach should be preferred over minimally invasive surgical 
step-up approach for the management of PFCs.
2.5 Endoscopic vs. surgical drainage: pseudocysts
Endoscopic and surgical cyst-gastrostomy have been compared in several studies 
[46–50]. Initial non-randomized trials found surgical drainage to be superior to 
endoscopic drainage of pseudocysts [50]. However, subsequent randomized studies 
concluded that endoscopic drainage achieves similar outcomes as compared to 
surgical drainage [46, 49, 47]. In addition, EUS guided cyst-gastrostomy is less 
invasive, cost saving, and associated with a shorter length of a post procedure 
hospital stay when compared with surgical cyst-gastrostomy [46, 47]. In a recent 
systematic review and meta-analysis including six studies (342 patients), there was 
no significant difference between surgical and endoscopic treatment success rates, 
adverse events, and recurrence for pancreatic pseudocysts [51]. To conclude, the 
current evidence suggests that endoscopic drainage is as efficacious as surgical cyst-
gastrostomy for pseudocysts with shorter hospital stay and reduced costs.
2.6 Endoscopic vs. percutaneous drainage
Percutaneous catheter drainage remains an important modality even in the 
era of minimally invasive endoscopic or surgical treatments. In different studies, 
percutaneous drainage alone was successful in 35–50% of cases with WON [52]. 
Percutaneous drainage can be used as an adjunctive to endoscopic drainage in 
selected cases with large PFCs extending into paracolic gutters or pelvis. In addi-
tion, percutaneous drainage is useful in acute or ill-defined PFCs (<4 weeks) where 
endoscopic drainage may not be feasible. Percutaneous tract can also be utilized for 
endoscopic and VARD [43]. Having described all the major advantages of percuta-
neous catheter drainage, the major limitation remains the development of external 
pancreatocutaneous fistula which may be difficult to treat.
As compared to percutaneous approach, endoscopic drainage is associated with 
significantly better clinical success, a lower re-intervention rate, and a shorter 
hospital length of stay [53]. Therefore, percutaneous drainage is only performed in 
cases where either endoscopic drainage is not available or not feasible (ill-defined or 
distantly located collections).
2.7 Dual modality drainage
Dual modality drainage (DMD) involves the simultaneous or sequential use of 
endoscopic and percutaneous approaches for symptomatic PFCs. Several studies 
have concluded the utility of DMD in symptomatic PFCs especially WON [54, 55]. 
The proposed advantages of this technique include a quicker recovery and reduced 
chances of forming an external pancreato-cutaneous fistula. In the study by Gluck 
et al., the use of DMD was associated with reduced length of hospital stay, and less 
requirement of radiological or endoscopic interventions [55].
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This technique may be especially useful in cases with large WON especially 
those extending into the paracolic gutters [56]. In these cases, transmural approach 
alone may not provide adequate drainage in these patients (Figure 6).
2.8 Trans-papillary drainage of PFCs
Trans-papillary drainage (TPD) of PFCs may be useful in certain scenarios as 
follows: (a) small size of cyst (<5 cm) communicating with main pancreatic duct 
(PD), (b) as an adjunct to ETD in cases with PD leak or disconnected PD, (c) 
chronic pancreatitis with an obstructed PD communicating with a pseudocyst, 
and (d) management of external pancreatic fistula after percutaneous or surgi-
cal drainage [22]. When used as a primary modality, TPD provides the path of 
least resistance for the pancreatic juice, thereby diverting it away from the cyst. 
There is a potential of cyst infection with TPD and therefore, antibiotics should 
be routinely given to these patients. TPD may be useful in preventing recur-
rences of PFCs following ETD in cases with PD leak and disconnected PD [57]. 
We do not routinely perform TPD as an adjunct to ETD in all the cases. In our 
practice, we evaluate the PD anatomy using an magnetic resonance cholangio-
pancreatogram (MRCP) prior to removal of stents placed during ETD. In cases 
with a PD stricture, leak or disconnection we attempt placing a trans-papillary 
PD stent. Subsequently, trans-papillary stents are removed or exchanged (as per 
the PD morphology) after 4–6 weeks. However, trans-papillary stenting may 
not be always feasible especially in cases with a disconnected PD. In these cases, 
transmural plastic stents can be left in situ and metal stents can be exchanged 
with plastic stents [58]. However, the latter approach needs to be substantiated by 
high quality randomized studies. Nevertheless, metal stents should be removed 
between 2 and 4 weeks irrespective of the PD anatomy due to the risk of buried 
stent syndrome and delayed bleeding.
2.9 Endoscopic drainage of PFC in children
The literature regarding the efficacy of endoscopic drainage of PFCs in children 
is sparse. Unlike adults, the feasibility of drainage using an adult duodenoscope or 
EUS scope is questionable in smaller children. Nevertheless, emerging data indicates 
that EUS-guided drainage is feasible and effective in children with PFCs [59–63]. 
Our group evaluated the long-term outcomes in 30 children with PFCs using pigtail 
plastic stents [60]. Clinical success was documented in 93% of children at a median 
follow up of 829 days. The use of novel metal stents has also been described in pedi-
atric age group [62, 61]. Nabi et al. used novel bi-flanged metal stents in 21 children 
with WON. Metal stents could be successfully placed in all the children, and clinical 
success was achieved in 95% of children [62].
3. Recent advancements
The technique of ETD of PFCs using metal stents requires a series of steps 
including needle puncture, coiling of guidewire in the cyst cavity, balloon dilatation 
of the cystogastric tract, and finally, deployment of stent. With the availability of 
electrocautery-enhanced delivery systems, the deployment of metal stents can be 
achieved in a single step [64, 65]. Therefore, the drainage of PFCs using these “Hot 
Devices” is quicker and simpler. Currently, the electrocautery-enhanced delivery 
system is available with lumen apposing (Hot AXIOS) as well as biflanged metal 
stents (Hot NAGI).
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4. Individualized approach to pancreatic fluid collections
The management of PFCs requires an individualized approach based on their 
maturity (acute or well defined), contents, and anatomical location in relation to 
gastroduodenal wall (Figure 7). Asymptomatic PFCs do not require drainage irre-
spective of their size. Similarly, symptomatic and ill-defined APFCs are managed 
conservatively with antibiotics (if necessary), nutritional support, and analgesics 
initially. In non-responders, percutaneous drainage is a reasonable next step in 
acute collections.
Mature PFCs with a well-defined wall and in close proximity to gastroduodenal 
wall can be managed endoscopically using plastic or metal endoprostheses in major-
ity of the cases. We prefer LCMS in PFCs containing substantial necrotic debris 
identified on EUS or MRI. Occasionally, the PFC is situated away (>1–1.5 cm) from 
the gastroduodenal wall and not amenable to endoscopic drainage. In these cases, 
percutaneous or minimally invasive surgical drainage (e.g., VARD) are alternatives.
Subsequent interventions are carried in a step-up fashion based on the per-
sistence of significant symptoms. Endoscopic or percutaneous necrosectomy is 
performed in non-responders who underwent ETD or percutaneous drainage, 
respectively, as the primary mode of drainage. We prefer intermediary steps includ-
ing naso-cystic lavage and de-clogging of LCMS before proceeding to DEN. In our 
experience, only a minor fraction of cases require DEN with this approach [14]. 
Some cases do not respond to the aforementioned minimally invasive step-up 
approach and require an open surgical debridement.
5. Conclusions
The management of PFCs requires a multidisciplinary approach involving 
experienced endoscopists, interventional radiologists, pancreatic surgeons, and 
nutritionists. Endoscopic drainage is the preferred first line approach to symptom-
atic and infected PFCs. Percutaneous drainage is useful in selected scenarios and 
can complement the benefits of endotherapy in large collections extending toward 
Figure 7. 
Approach to symptomatic pancreatic fluid collections. VARD, video-assisted retroperitoneal debridement; 
LCMS, large caliber metal stent; **percutaneous drainage can be performed either simultaneously with 
endoscopic transmural drainage or sequentially in non-responders.
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pelvis. The approach to PFCs should not be rigid and should be individualized for 
each patient. In general, a step-up approach minimizes the morbidity associated 
with open surgical drainage and is usually successful in majority of the patients. 
However, some cases do require open surgical debridement despite of all the recent 
advancements in endotherapy.
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